- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
NEW YORK ( TheStreet) -- Actavis (NYSE: ACT) hit a new 52-week high Monday as it is currently trading at $137.08, above its previous 52-week high of $136.73 with 369,722 shares traded as of 10:46 a.m. ET. Average volume has been 1.7 million shares over the past 30 days. Actavis has a market cap of $18.08 billion and is part of the health care sector and drugs industry. Shares are up 58% year to date as of the close of trading on Friday. Actavis, Inc., an integrated specialty pharmaceutical company, engages in developing, manufacturing, marketing, selling, and distributing generic, branded generic, brand, biosimilar, and over-the-counter pharmaceutical products worldwide.